NAV
$68.98
AUM
$324.5M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.15% | +2.30% | +7.50% | +16.03% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.93% |
| 2 | NOVN.SW | Novartis AG Registered Shares | 1.48% |
| 3 | RY | Royal Bank of Canada | 1.47% |
| 4 | HSBA.L | HSBC Holdings PLC | 1.34% |
| 5 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.34% |
| 6 | AZN.L | AstraZeneca PLC | 1.31% |
| 7 | ABBN.SW | ABB Ltd | 1.29% |
| 8 | SU.PA | Schneider Electric SE | 1.24% |
| 9 | TD | The Toronto-Dominion Bank | 1.06% |
| 10 | 8306.T | Mitsubishi UFJ Financial Group Inc | 0.93% |
The index is composed of large- and mid-cap developed market equities, excluding the U.S., that are selected and weighted so that, in the aggregate, the portfolio is compatible with the objectives of the Paris Agreement by following a decarbonization trajectory, reducing exposure to climate-related transition and physical risks and increasing exposure to companies favorably positioned for the transition to a low-carbon economy. The fund generally will invest at least 90% of its assets in the component securities of its index.
Inception Date: 2024-01-17